1 Patent
- US125595642026Compositions and Methods for Preventing or Reversing T-cell Exhaustion Through Ectonucleotidase Inhibition and Antibody-mediated Target Cytosis
Antagen Institute For Biomedical Research
0 cites
Antagen Institute For Biomedical Research